The Aroon Indicator for CMGMY entered a downward trend on November 12, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 70 similar instances where the Aroon Indicator formed such a pattern. In of the 70 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CMGMY as a result. In of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CMGMY turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at .
The 50-day moving average for CMGMY moved below the 200-day moving average on December 10, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CMGMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.409) is normal, around the industry mean (8.210). P/E Ratio (20.827) is within average values for comparable stocks, (56.879). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.337). Dividend Yield (0.023) settles around the average of (0.016) among similar stocks. P/S Ratio (1.743) is also within normal values, averaging (8.614).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CMGMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry AerospaceDefense
A.I.dvisor tells us that CMGMY and BUKS have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMGMY and BUKS's prices will move in lockstep.
Ticker / NAME | Correlation To CMGMY | 1D Price Change % | ||
---|---|---|---|---|
CMGMY | 100% | -4.86% | ||
BUKS - CMGMY | 4% Poorly correlated | +4.00% | ||
BAESY - CMGMY | 3% Poorly correlated | -1.82% | ||
CITAF - CMGMY | 1% Poorly correlated | -2.31% | ||
AVNBF - CMGMY | 1% Poorly correlated | N/A | ||
BAESF - CMGMY | -0% Poorly correlated | -0.72% | ||
More |